Biomaterial Market By 2023 to 2033: The Role of 3D Printing Technologies

BySanket Badgujar
Biomaterials Market

The global biomaterial market is poised for an unprecedented growth trajectory, as forecasted figures suggest a staggering surge from its 2023 valuation of USD 1,72,689.3 million to an estimated USD 3,86,983.6 million by 2033. This remarkable growth rate of 8.4% within the biodegradable Biomaterial Market signals a promising trajectory for the next decade and beyond.

The exponential expansion of the biomaterial market underscores its growing significance across diverse industries, ranging from healthcare to environmental sustainability. This growth serves as a testament to the pivotal role biomaterials play in driving innovation and addressing global challenges. Furthermore, the market’s evolution not only presents opportunities for groundbreaking advancements but also positions itself as a key player in contributing to global economic growth.

Request to Sample of this Report: https://www.futuremarketinsights.com/reports/sample/rep-gb-15168

Driven by escalating demands for sustainable solutions and advancements in biotechnology, the biomaterial industry is carving a path towards substantial market value, indicating a shift towards eco-friendly, biodegradable materials. This evolution is expected to reshape various sectors, including healthcare, packaging, and consumer goods, fostering a transition towards greener, more sustainable practices.

The projected surge in the biomaterial market invites attention from investors, innovators, and industry stakeholders seeking to capitalize on this burgeoning sector. Its growth trajectory not only signifies economic opportunities but also underscores a global commitment towards sustainable practices and environmentally conscious solutions.

As we navigate towards a more sustainable future, the biomaterial market stands as a beacon of innovation and progress, driving transformative change across industries and shaping a world that embraces eco-friendly practices.

Bridging the Gap Between Science and Healthcare Needs with Biomaterials:

The biomaterials and tissue engineering market is expanding due to the aging population, increased incidence of cardiovascular and orthopedic issues, technical medical developments, and rising public awareness of implantable devices. Increasing consumer awareness of the advantages of products based on biomaterials and increased government funding for biomaterials research and development are contributing to the market expansion.

Compatibility issues and expensive implants are expected to restrict global Biomaterial Market growth. On the other hand, new product introductions in plastic surgery, wound healing, and neurology are anticipated to present lucrative opportunities for growth in the Biomaterial Market. Examples of these products include hydrogen scaffolding and decellularized dermal matrixes for grafting.

The Role of Polymers in Market Revenue for Biomaterials:

The polymer sector dominated the global Biomaterial Market revenue in 2023 and is expected to maintain its dominance. This is attributable mainly to the variety of uses for polymer goods. The segment’s revenue growth is anticipated to accelerate due to the wide availability of biopolymers and the demand for advanced polymers for use in bio-resorbable tissue fixation applications and other orthopedic applications.

“Increasing consumer awareness of the advantages of products based on biomaterials and increased government funding for biomaterials research and development are contributing to the market expansion.” opines Sabyasachi Ghosh Associate Vice President at Future Market Insights (FMI) analyst.

Key Takeaways:

  • The polymer biomaterials segment of the material type category to grab a share of 33.5% by 2033.
  • In the end-user category, the cardiology segment accounts for a market share of 21.1% during the forecast period.
  • By 2033, the United States market is expected to possess a 23.2% share.
  • The North America market is forecast to have a 28.5% market share by 2033.
  • By 2033, Germany is expected to hold 4.7% of the market share.
  • Until 2033, the China may grab a share of 8.3%.
  • The India market is going to continue to hold a share of 8% through 2033.
  • Until 2033, the market in the United Kingdom is anticipated to grab a share of 4%.
  • The United States market to exhibit a CAGR of 6% from 2023 to 2033.
  • The United Kingdom market to register a CAGR of 5.5% between 2023 and 2033.
  • Germany market to develop at a CAGR of 6.1% between 2023 and 2033.
  • China market to record a CAGR of 13.3% through 2033.
  • India market is to exhibit a CAGR of 15% from 2023 to 2033.

 

Competitive Analysis:

Important biomaterials manufacturers invest heavily to grow their presence and keep a competitive edge. They are also implementing techniques to improve their product catalog, including contracts, collaborations, and collaborative models. Significant biomaterials manufacturers are prone to creating more inventive items to increase their selection of biomaterials.

Recent Breakthroughs:

  • To create bioprinted tissue treatments for obesity and diabetes, Novo Nordisk partnered with Aspect Biosystems, a business that produces bioprinted biomaterials, in April 2023.
  • After the Huafon Group purchased DuPont Biomaterials, Covation Biomaterials, a global provider of bio-based solutions, was born as a separate company in June 2022.
  • DuPont and JP Modatex India debuted a new spun yarn collection in April 2022 that combines natural fibers with DuPont Sorona staple fibers. The group makes spun yarns appropriate for various uses, including dresses, shirting, pants and skirts, jeans, and jackets, by combining linen and partially plant-based Sorona fibers.

Key Biomaterials Manufacturers:

  • BASF SE
  • Evonik Industries AG
  • Royal DSM N.V.
  • Corbion N.V.
  • Covestro AG
  • Zimmer Biomet Holdings, Inc.
  • Stryker Corporation
  • Medtronic plc
  • DENTSPLY SIRONA Inc.
  • Wright Medical Group N.V.
  • Baxter International Inc.
  • Integra LifeSciences Holdings Corporation
  • Johnson & Johnson
  • Carpenter Technology Corporation
  • Invibio Ltd.
  • CAM Bioceramics B.V.
  • Biomatlante
  • Biomet, Inc.
  • Aap Implantate AG
  • Orthofix Medical Inc.

Key Segments:

By Material Type:

  • Ceramic Biomaterials
  • Surface Reactive/Bioactive
  • Non-Absorbable
  • Polymer Biomaterials
  • Metallic Biomaterials
  • Natural Materials
  • Other Materials

By Application:

  • Cardiology
  • Ophthamology
  • Dental
  • Neurology
  • Orthopaedic
  • Respiratory
  • Wound Management
  • Aesthetic & Plastic Surgery
  • Tissue Engineering & Regenerative Medicine
  • Other Applications

By End Users:

  • Pharmaceuticals/Biotech Manufacturers
  • Medical Device Manufacturers
  • Cosmetic & Aesthetic Products Manufacturers
  • Tissue Engineering and Regenerative Medicine Companies
  • Research Laboratories
  • Acaedmic Institutions

By Region:

  • North America
  • Latin America
  • East Asia
  • South Asia Pacific
  • Western Europe
  • Eastern Europe
  • The Middle East & Africa